1. In this randomized control trial, pegylated interferon lambda reduced the risk of coronavirus disease 2019 (COVID-19)-related hospitalization as compared ...
1. In a systematic review and meta-analysis of randomized trials and cohort studies in children 5 to 11 years old, ...
1. Among patients with primary Sjögren syndrome, therapy with low-dose interleukin 2 significantly improved outcomes as determined by the European ...
1. Self-administered subcutaneous immunoglobulin therapy in the treatment of immunodeficiencies is significantly less costly compared to clinic-administered intravenous immunoglobulin therapy. ...
1. The monoclonal antibody CIS43LS was associated with dose-dependent protection against malaria infection in adults in Mali. 2. CIS43LS had ...
1. Two doses of the Moderna coronavirus disease 2019 (COVID-19) vaccine were not associated with a significant increase in serious ...
1. In comparison to vehicle-control, a greater proportion of patients using ruxolitinib achieved a reduction in facial Vitiligo Area Scoring ...
1. Patients with the ACKR1 variant (CC genotype) had an elevated risk of azathioprine discontinuation attributed to hematopoietic toxicity. 2. ...
1. In patients with sepsis receiving a vasopressor in the intensive care unit (ICU), intravenous vitamin C was associated with ...
1. Compared to placebo, children who received peanut oral immunotherapy experienced significantly greater desensitization and remission. 2. Younger age at ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.